ALEXANDRIA, Va. – The National Community Pharmacists Association (NCPA) issued the following statement on behalf of NCPA CEO B. Douglas Hoey in reaction to a deadlock vote by the FTC on whether to investigate PBMs, effectively killing the proposal at least for now:

B. Douglas Hoey

“Two members of the FTC just let the worst actors in the market off the hook. After hearing hours of testimony by community pharmacists and patients, all of whom painted the same shocking picture about PBM abuse, and not a single witness there to defend the PBM industry, it is inexplicable that two members of the commission could vote against the study. Their decisions could not possibly have been based on what was heard today.

“We’re grateful to Chairwoman Khan for bringing this issue to a vote. We will demand she do so again at the soonest possible opportunity. However, this is extremely disappointing.”

For more information about NCPA, please visit www.ncpa.org.